Protheragen Advances Gene Therapy Research with Adeno-Associated...

added blog Science & Tech

2025-06-27 06:31:10 -

Protheragen Advances Gene Therapy Research with Adeno-Associated Virus (AAV) Vector Platform

Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development. Adeno-associated virus (AAV) is a non-enveloped virus that can transport DNA to target cells through genetic engineering, and it has...

0 Comments 0 Shares 13 Views 0 Reviews